175 related articles for article (PubMed ID: 37955319)
1. False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
Schürfeld R; Pamporaki C; Peitzsch M; Rayes N; Sabri O; Rohm S; Biemann R; Sandner B; Tönjes A; Eisenhofer G
Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37955319
[TBL] [Abstract][Full Text] [Related]
2. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.
Eisenhofer G; Goldstein DS; Walther MM; Friberg P; Lenders JW; Keiser HR; Pacak K
J Clin Endocrinol Metab; 2003 Jun; 88(6):2656-66. PubMed ID: 12788870
[TBL] [Abstract][Full Text] [Related]
3. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
4. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
5. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
6. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
[TBL] [Abstract][Full Text] [Related]
7. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
[TBL] [Abstract][Full Text] [Related]
9. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
[TBL] [Abstract][Full Text] [Related]
10. Laboratory evaluation of pheochromocytoma and paraganglioma.
Eisenhofer G; Peitzsch M
Clin Chem; 2014 Dec; 60(12):1486-99. PubMed ID: 25332315
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
12. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
Bokuda K; Yatabe M; Seki Y; Ichihara A
Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
[TBL] [Abstract][Full Text] [Related]
13. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
[TBL] [Abstract][Full Text] [Related]
14. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
[TBL] [Abstract][Full Text] [Related]
15. Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine.
Peitzsch M; Novos T; Kaden D; Kurlbaum M; van Herwaarden AE; Müller D; Adaway J; Grouzmann E; McWhinney B; Hoad K; Woollard G; Kema I; Boot C; Fassnacht M; Sweep F; Loh TP; Horvath AR; Eisenhofer G
Clin Chem; 2021 Aug; 67(8):1098-1112. PubMed ID: 33993248
[TBL] [Abstract][Full Text] [Related]
16. Age-specific pediatric reference intervals for plasma free normetanephrine, metanephrine, 3-methoxytyramine and 3-O-methyldopa: Particular importance for early infancy.
Peitzsch M; Mangelis A; Eisenhofer G; Huebner A
Clin Chim Acta; 2019 Jul; 494():100-105. PubMed ID: 30904545
[TBL] [Abstract][Full Text] [Related]
17. Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
Därr R; Pamporaki C; Peitzsch M; Miehle K; Prejbisz A; Peczkowska M; Weismann D; Beuschlein F; Sinnott R; Bornstein SR; Neumann HP; Januszewicz A; Lenders J; Eisenhofer G
Clin Endocrinol (Oxf); 2014 Apr; 80(4):478-86. PubMed ID: 24102244
[TBL] [Abstract][Full Text] [Related]
18. Biochemical Assessment of Pheochromocytoma and Paraganglioma.
Eisenhofer G; Pamporaki C; Lenders JWM
Endocr Rev; 2023 Sep; 44(5):862-909. PubMed ID: 36996131
[TBL] [Abstract][Full Text] [Related]
19. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
Eisenhofer G; Lenders JW; Timmers H; Mannelli M; Grebe SK; Hofbauer LC; Bornstein SR; Tiebel O; Adams K; Bratslavsky G; Linehan WM; Pacak K
Clin Chem; 2011 Mar; 57(3):411-20. PubMed ID: 21262951
[TBL] [Abstract][Full Text] [Related]
20. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
